Yersinia Infections: Clinical Trials

6 trials for Yersinia Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Unknown 1
Phase 31Completed 1

Follow Yersinia Infections: new trials by email Literature Review of Yersinia Infections trials Research Report on Yersinia Infections

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
rF1V-1018, rF1V vaccine - Plague, Pneumonic, Plague
Phase 2CompletedDynavax Technologies Corporation2002022-08-092025-07-29
Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens
plague vaccine(F1+rV) - Plague
Phase 2UnknownJiangsu Province Centers for Disease Control and Prevention7202020-05-082022-04-15
Immunogenicity and Safety of Subunit Plague Vaccine
Plague vaccine - Plague
Phase 2CompletedJiangsu Province Centers for Disease Control and Prevention2402014-10-012015-11-04
A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans
ciprofloxacin, doxyxcycline - Plague
Phase 2CompletedCenters for Disease Control and Prevention52010-12-012026-06-03
Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
rF1V vaccine (with Adjuvant), rF1V vaccine (without Adjuvant) - Plague Vaccine
Phase 2CompletedDynPort Vaccine Company LLC, A GDIT Company4022010-07-012020-07-30
Treatment and Diagnosis of Plague
gentamicin, streptomycin - Plague
Phase 2 / Phase 3CompletedCenters for Disease Control and Prevention1142004-08-012009-02-26

Narrower conditions

Plague (6)  ·  Vaccine-Preventable Diseases (1)

Broader conditions

Bacterial Infections (6)  ·  Bacterial Infections and Mycoses (6)  ·  Enterobacteriaceae Infections (6)  ·  Gram-Negative Bacterial Infections (6)  ·  Infections (6)  ·  Vector Borne Diseases (6)

Interventions

Adjuvants, Pharmaceutic (1)  ·  Ciprofloxacin (1)  ·  Gentamicins (1)  ·  Plague Vaccine (1)  ·  Streptomycin (1)

Sponsors

Centers for Disease Control and Prevention (2)  ·  Jiangsu Province Centers for Disease Control and Prevention (2)  ·  DynPort Vaccine Company LLC, A GDIT Company (1)  ·  Dynavax Technologies Corporation (1)

Countries

China (2)  ·  United States (2)  ·  Madagascar (1)  ·  Uganda (1)

Top investigators

Edward Mbidde, MD (1)  ·  Fengcai Zhu, Master (1)  ·  George Saviolakis, MD (1)  ·  Issa Makumbi, MD (1)  ·  Kevin Griffith, MD, MPH (1)  ·  Kevin S. Griffith, MD, MPH (1)  ·  Martin Schriefer, PhD (1)  ·  Yuemei Hu, Bachelor (1)

Results publications

PMID 29927704